The Celsis Accel system allows products to be quickly released from micro hold, reducing manufacturing cycle times and inventory requirements for home, beauty and pharmaceutical product manufacturers.
The system reduces time necessary for quality control assessment of microbial contamination. This shortens production cycle times by lowering quarantined inventory levels awaiting quality control release and reduces working capital requirements. Faster quality control results provide an earlier indication of contamination, allowing more effective investigation and corrective action.
The product takes the robustness and ease of use of the Celsis Advance platform packaged into a compact system designed for small and medium-sized manufacturing facilities. Easy-to-use, easy-to-learn software makes the product suitable for home, beauty and pharmaceutical product manufacturers’ microbiology labs.
Celsis adapted the familiar sample tube platform to a precision movement carousel for easy loading and fast processing, with the ability to run 30 assays at a time. A fourth injector position gives the system flexibility to use new reagent technologies as they are developed. From reagent bottle access to sample loading, the ergonomic design puts everything at the fingertips of the user.
Celsis Accel.im takes advantage of software innovations such as a ribbon menu system, data security features and the ability to export sample results. User administration features, an event log and more allow full compliance with the FDA’s CFR 21 Part 11 and the EU’s Annex 11.
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
Grace Bio-Labs protein microarray tools
Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...
Siemens Healthineers 3gAllergy assay
Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...